Search our Database of Scientific Publications and Authors

I’m looking for a

    Details and Download Full Text PDF:
    A new quantitative PCR for human parvovirus B19 genotypes.

    J Virol Methods 2015 Jun 17;218:40-5. Epub 2015 Mar 17.
    University of Helsinki, Department of Virology, Haartmaninkatu 3, 00290 Helsinki, Finland; Helsinki University Hospital Laboratory Division, Haartmaninkatu 3, 00290 Helsinki, Finland.
    Parvovirus B19 (B19V) is a minute ssDNA virus associated with a wide range of diseases from childhood erythema to fetal death. After primary infection, the viral genomes persist lifelong in solid tissues of most types. Quantification of the viral DNA is important in the timing of primary infection, assessment of tissue persistence and screening of blood donor plasma. In this study, we present a new PCR assay for detection and quantification as well as for differentiation of all three B19V genotypes. A new B19V qPCR was designed to target a 154-bp region of the NS1 area. Serum, plasma and solid tissue samples were suitable for testing in the assay. The WHO International Reference Panel for Parvovirus B19 Genotypes was utilized to validate the assay for detection of different genotypes of B19V in clinical material. Each panel member yielded, by the new qPCR, a quantity similar to the one reported by National Institute for Biological Standards and Control (NIBSC). The qPCR was specific for B19V and amplified and quantified all three genotypes with detection sensitivities of ≤10 copies/reaction. The differentiation of B19V genotypes was performed by Sanger sequencing of the amplified products.
    PDF Download - Full Text Link
    ( Please be advised that this article is hosted on an external website not affiliated with
    Source Status ListingPossible

    Similar Publications

    Quantitation of human parvovirus B19 DNA in erythema infectiosum and aplastic crisis.
    J Med Virol 2014 Dec 24;86(12):2102-6. Epub 2014 Jun 24.
    Department of Pediatrics, Sapporo Medical University School of Medicine, Sapporo, Japan.
    Several publications concerning the methods of real-time PCR for human parvovirus B19 (B19V) have appeared and some case reports mention B19V DNA loads. However, no large-scale study quantitating levels of B19V DNA in common or representative B19V manifestations such as erythema infectiosum and aplastic crisis has been performed. Consequently, using the TaqMan PCR assay, the B19V load in a large sample of subjects with erythema infectiosum or aplastic crisis was quantitated. Read More
    Validation of new real-time polymerase chain reaction assays for detection of hepatitis A virus RNA and parvovirus B19 DNA.
    Transfusion 2016 Feb 9;56(2):440-8. Epub 2015 Sep 9.
    National Screening Laboratory, Sanquin Diagnostic Services, Amsterdam, the Netherlands.
    Background: To meet European guidelines for plasma for fractionation, plasma fractionators have implemented parvovirus B19 (B19V) and hepatitis A virus (HAV) nucleic acid test (NAT) screening on test pools. In this study we evaluate recently developed in-house NAT assays for B19V DNA and HAV RNA. The B19V NAT was designed to target two different regions of the B19V genome. Read More
    Existence of various human parvovirus B19 genotypes in Chinese plasma pools: genotype 1, genotype 3, putative intergenotypic recombinant variants and new genotypes.
    Virol J 2016 09 17;13(1):155. Epub 2016 Sep 17.
    Laboratory for Viral Safety of National Centre of Biomedical Analysis, Beijing Institute of Transfusion Medicine, No. 27 Taiping road, Haidian District, Beijing, 100850, China.
    Background: Human parvovirus B19 (B19V) is a frequent contaminant of blood and plasma-derived medicinal products. Three distinct genotypes of B19V have been identified. The distribution of the three B19V genotypes has been investigated in various regions or countries. Read More
    Keeping pace with parvovirus B19 genetic variability: a multiplex genotype-specific quantitative PCR assay.
    J Clin Microbiol 2013 Nov 4;51(11):3753-9. Epub 2013 Sep 4.
    Department of Pharmacy and Biotechnology.
    Three genotypes have been identified within the parvovirus B19 species (B19V), and such genetic diversity may have significant implications for the development of molecular detection assays. In the present study, B19V genetic variability has been examined on a subset of genomic sequences available in the NCBI nucleotide database, and a quantitative PCR (qPCR) assay able to detect, differentiate, and quantify all viral variants has been established. The designed primers and probes have been used for the development of alternative detection formats, based on a combined use of intercalating dye and genotype-specific hydrolysis probes. Read More